CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 184 filers reported holding CLOVIS ONCOLOGY INC in Q2 2015. The put-call ratio across all filers is 1.20 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $3,094,000 | -43.9% | 208,053 | -6.4% | 0.10% | -42.1% |
| Q1 2019 | $5,514,000 | +45.9% | 222,165 | +5.6% | 0.18% | +29.0% |
| Q4 2018 | $3,779,000 | -13.8% | 210,422 | +41.0% | 0.14% | -12.1% |
| Q3 2018 | $4,382,000 | -37.5% | 149,212 | -3.2% | 0.16% | -38.4% |
| Q2 2018 | $7,008,000 | -10.4% | 154,115 | +4.1% | 0.26% | -16.4% |
| Q1 2018 | $7,819,000 | -22.1% | 148,079 | +0.3% | 0.30% | -22.8% |
| Q4 2017 | $10,040,000 | +0.1% | 147,650 | +21.4% | 0.40% | -11.0% |
| Q3 2017 | $10,025,000 | -15.3% | 121,665 | -3.8% | 0.44% | -13.8% |
| Q2 2017 | $11,836,000 | +84.2% | 126,413 | +25.3% | 0.52% | +64.5% |
| Q1 2017 | $6,426,000 | +38.7% | 100,926 | -3.2% | 0.31% | +33.8% |
| Q4 2016 | $4,633,000 | +21.0% | 104,308 | -1.8% | 0.23% | +17.0% |
| Q3 2016 | $3,829,000 | +195.0% | 106,207 | +12.3% | 0.20% | +166.7% |
| Q2 2016 | $1,298,000 | -27.2% | 94,594 | +1.8% | 0.08% | -27.2% |
| Q1 2016 | $1,783,000 | -42.8% | 92,878 | +4.3% | 0.10% | -42.1% |
| Q4 2015 | $3,116,000 | -32.2% | 89,023 | +78.0% | 0.18% | -40.3% |
| Q3 2015 | $4,599,000 | +77.4% | 50,008 | +69.6% | 0.30% | +98.7% |
| Q2 2015 | $2,592,000 | +7.9% | 29,492 | -8.8% | 0.15% | +7.9% |
| Q1 2015 | $2,402,000 | – | 32,355 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |